Horizon Therapeutics plc Ranked #1 in Overall Corporate Reputation Among U.S. Patient Groups that Report Working with the Company

Author's Avatar
May 13, 2021

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked #1 in overall corporate reputation among U.S. patient groups that reported working with the company, and #2 in overall corporate reputation among U.S. patient groups familiar with the company. These results are based on PatientView’s annual survey of 207 U.S. patient groups who evaluated 38 pharmaceutical and biotechnology companies.